Glenn E Richman

Array ( [id] => 5374147 [patent_doc_number] => 20090311708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON ERCC1 AND TS EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/502753 [patent_app_country] => US [patent_app_date] => 2009-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12654 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311708.pdf [firstpage_image] =>[orig_patent_app_number] => 12502753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81771 [patent_doc_number] => 07745399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/395818 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11015 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745399.pdf [firstpage_image] =>[orig_patent_app_number] => 12395818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5323520 [patent_doc_number] => 20090061510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'ANTI-ANGIOGENIC POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/183896 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 19392 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20090061510.pdf [firstpage_image] =>[orig_patent_app_number] => 12183896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759358 [patent_doc_number] => 20080311584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Methods for Detection of Mutations in Myostatin Variants' [patent_app_type] => utility [patent_app_number] => 12/130771 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13639 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311584.pdf [firstpage_image] =>[orig_patent_app_number] => 12130771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949005 [patent_doc_number] => 20080305131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Cancer Immunotherapy with Semi-Allogeneic Cells' [patent_app_type] => utility [patent_app_number] => 12/115868 [patent_app_country] => US [patent_app_date] => 2008-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 19762 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305131.pdf [firstpage_image] =>[orig_patent_app_number] => 12115868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886369 [patent_doc_number] => 20080260701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'ANTI-ANGIOGENIC CELLULAR AGENT FOR CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/058538 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11048 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260701.pdf [firstpage_image] =>[orig_patent_app_number] => 12058538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682787 [patent_doc_number] => 20080249013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Vaccines' [patent_app_type] => utility [patent_app_number] => 11/949977 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 33139 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249013.pdf [firstpage_image] =>[orig_patent_app_number] => 11949977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4926998 [patent_doc_number] => 20080166361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Neutron Capture Therapy' [patent_app_type] => utility [patent_app_number] => 11/950908 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9013 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166361.pdf [firstpage_image] =>[orig_patent_app_number] => 11950908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698830 [patent_doc_number] => 20080221014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Method of Diagnosing and Treating Glioma' [patent_app_type] => utility [patent_app_number] => 11/946449 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 40910 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221014.pdf [firstpage_image] =>[orig_patent_app_number] => 11946449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 167101 [patent_doc_number] => 07666389 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Method of imaging cell death in vivo' [patent_app_type] => utility [patent_app_number] => 11/985567 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 9507 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666389.pdf [firstpage_image] =>[orig_patent_app_number] => 11985567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 169777 [patent_doc_number] => 07662378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Antibody therapy' [patent_app_type] => utility [patent_app_number] => 11/932530 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 26650 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662378.pdf [firstpage_image] =>[orig_patent_app_number] => 11932530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 84006 [patent_doc_number] => 07741433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/929570 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 53 [patent_no_of_words] => 297252 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741433.pdf [firstpage_image] =>[orig_patent_app_number] => 11929570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938386 [patent_doc_number] => 20080075705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Method for increasing tumor cell immunogenicity using heat shock protein' [patent_app_type] => utility [patent_app_number] => 11/975236 [patent_app_country] => US [patent_app_date] => 2007-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5970 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20080075705.pdf [firstpage_image] =>[orig_patent_app_number] => 11975236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785002 [patent_doc_number] => 20080138331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'DIAGNOSTIC AND THERAPEUTIC METHODS BASED ON THE L1 ADHESION MOLECULE FOR OVARIAN AND ENDOMETRIAL TUMORS' [patent_app_type] => utility [patent_app_number] => 11/865989 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5039 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138331.pdf [firstpage_image] =>[orig_patent_app_number] => 11865989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894000 [patent_doc_number] => 20080103099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Apoptin-associating protein' [patent_app_type] => utility [patent_app_number] => 11/906493 [patent_app_country] => US [patent_app_date] => 2007-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9043 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103099.pdf [firstpage_image] =>[orig_patent_app_number] => 11906493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4704108 [patent_doc_number] => 20080063631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'APOPTOTIC ENTITIES FOR USE IN TREATMENT OF ENDOTHELIUM DYSFUNCTION DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/855092 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4863 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20080063631.pdf [firstpage_image] =>[orig_patent_app_number] => 11855092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697841 [patent_doc_number] => 20080220025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Treating Tumors Using Implants Comprising Combinations of Allogeneic Cells' [patent_app_type] => utility [patent_app_number] => 11/854014 [patent_app_country] => US [patent_app_date] => 2007-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21166 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20080220025.pdf [firstpage_image] =>[orig_patent_app_number] => 11854014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697783 [patent_doc_number] => 20080219967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases' [patent_app_type] => utility [patent_app_number] => 11/891847 [patent_app_country] => US [patent_app_date] => 2007-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18414 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20080219967.pdf [firstpage_image] =>[orig_patent_app_number] => 11891847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5198702 [patent_doc_number] => 20070298020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'APOPTOTIC ENTITIES FOR USE IN TREATMENT OF ENDOTHELIUM DYSFUNCTION DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/831261 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4802 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298020.pdf [firstpage_image] =>[orig_patent_app_number] => 11831261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772608 [patent_doc_number] => 20080058267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Apoptin-associating protein' [patent_app_type] => utility [patent_app_number] => 11/879370 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9022 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058267.pdf [firstpage_image] =>[orig_patent_app_number] => 11879370 [rel_patent_id] =>[rel_patent_doc_number] =>)